<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04136041</url>
  </required_header>
  <id_info>
    <org_study_id>19-33</org_study_id>
    <nct_id>NCT04136041</nct_id>
  </id_info>
  <brief_title>Study Protocol for a Smartphone Application-based Intervention for Subthreshold Depression</brief_title>
  <official_title>Study Protocol for a Pilot Randomized Controlled Trial on a Smartphone Application-based Intervention for Subthreshold Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kibi International University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kibi International University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators plan to conduct a randomized controlled trial to examine whether a
      Smartphone-based Intervention improves subthreshold depression symptoms compared to no
      intervention.

      The purpose of this pilot randomized controlled trial is to investigate the feasibility of
      the final randomized controlled trial.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 29, 2019</start_date>
  <completion_date type="Actual">March 5, 2020</completion_date>
  <primary_completion_date type="Actual">March 5, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Depression severity as measured by the Center for Epidemiologic Studies Depression Scale (CES-D) score.</measure>
    <time_frame>Change from Baseline CES-D at 5 weeks</time_frame>
    <description>The CES-D is a 20-item self-report questionnaire used to measure depressive symptoms. The CES-D is a four-point Likert scale, with each item scored from 0 to 3. The total score ranges from 0 to 60 points. The higher the score, the stronger the depressive symptoms.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Psychological distress as measured by the Kessler Screening Scale for Psychological Distress (K6) score.</measure>
    <time_frame>Change from Baseline K6 at 5 weeks</time_frame>
    <description>The K6 is a 6-item self-report questionnaire used to measure psychological distress. The K6 is a five-point Likert scale, with each item scored from 0 to 4. The total score ranges from 0 to 24 points. The higher the score, the stronger the psychological distress.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety as measured by the 7-item Generalized Anxiety Disorder Scale (GAD-7).</measure>
    <time_frame>Change from Baseline GAD-7 at 5 weeks</time_frame>
    <description>The GAD-7 is a 7-item self-report questionnaire used to measure anxiety. The GAD-7 is a four-point Likert scale, with each item scored from 0 to 3. The total score ranges from 0 to 21 points. The higher the score, the stronger the anxiety.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Subthreshold Depression</condition>
  <arm_group>
    <arm_group_label>Smartphone Application</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants watch a video using the Smartphone Application displaying positive word stimuli.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Intervention</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No Intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Smartphone Application</intervention_name>
    <description>The experimental group will watch movies using the Smartphone application for at least 10 min a day for 5 weeks.</description>
    <arm_group_label>Smartphone Application</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 Years and older

          -  Males and females

          -  Center for Epidemiologic Studies Depression Scale score ≥16

          -  Written informed consent prior to participation

          -  Owns a smartphone with the iOS® operating system

        Exclusion Criteria:

          -  Lifetime history of psychiatric disorders

          -  Currently receiving treatment for a mental health problem from a mental health
             professional

          -  Experience of a major depressive episode in the 2 weeks prior to the study, as
             ascertained using the Mini-International Neuropsychiatric Interview

          -  Vision or hearing deficits that negatively impact everyday life
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kibi International University</name>
      <address>
        <city>Takahashi</city>
        <state>Okayama</state>
        <zip>716-8508</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>October 21, 2019</study_first_submitted>
  <study_first_submitted_qc>October 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 23, 2019</study_first_posted>
  <last_update_submitted>March 30, 2020</last_update_submitted>
  <last_update_submitted_qc>March 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kibi International University</investigator_affiliation>
    <investigator_full_name>Kazuki Hirao, PhD, OT</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

